<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The echocardiographic diagnosis of cardiac <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e>, vegetations and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> as well as the identification of predisposing conditions such as <z:hpo ids='HP_0001655'>patent foramen ovale</z:hpo>, aortic <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and other minor causes (e.g., <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo>, mitral and <z:hpo ids='HP_0004380'>aortic valve calcification</z:hpo>) have crucial clinical relevance, affecting the choice of surgery and/or of pharmaceutical therapy in the setting of patients presenting embolism </plain></SENT>
<SENT sid="1" pm="."><plain>The echocardiographic assessment helps not only for the retrospective diagnosis of sources of embolism but also for the prevention of events in asymptomatic patients </plain></SENT>
<SENT sid="2" pm="."><plain>Echocardiography can also distinguish <z:mpath ids='MPATH_458'>normal</z:mpath> variants and artifacts from cardiac masses and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Echocardiographic characterization/typology of cardiac sources of embolism is currently below par when compared with cardiac MRI, the current gold standard </plain></SENT>
<SENT sid="4" pm="."><plain>Nevertheless, echocardiography remains the 'first-line' imaging tool, because of its low cost and the possibility to add easily available, functional and structural information at the patient's bedside </plain></SENT>
</text></document>